Project HERO: Health Empowerment & Recovery Outcomes

Summary

Project HERO is a 12-week study of the efficacy of Body Mind Training (BMT, i.e. Tai Chi and Qigong in this project) for reducing fatigue in male cancer survivors. This 3-arm randomized clinical trial will examine inflammatory biology and selected gene-expression pathways that are hypothesized to contribute to the intervention's effect.

Conditions

• Prostate Cancer
• Bladder Cancer
• Kidney Cancer
• Colon Cancer
• Rectum Cancer
• Thyroid Cancer
• Lung Cancer
• Small Intestine Cancer
• Soft Tissue Cancer

Interventions

BEHAVIORAL

Body Mind Training (BMT)

Participants will practice BMT under the instruction of a BMT instructor. There will be 24 sessions. Each session will last 60 minutes and will occur twice a week for 12 weeks. Each session will include both light physical exercise and mind training. Sessions will be supplemented with home-based practice using an instructional DVD and handouts. Participants will be instructed to practice at least 30 minutes a day (at least 3 days per week) throughout the intervention and post-intervention period.

BEHAVIORAL

Body Training (BT):

Participants will practice BT under the instruction of a BT instructor. There will be 24 sessions. Each session will last 60 minutes and will occur twice a week for 12 weeks. Sessions will be supplemented with home-based practice using an instructional DVD and handouts. Participants will be instructed to practice at least 30 minutes a day (at least 3 days per week) throughout the intervention and post-intervention period.

BEHAVIORAL

Usual Care (UC)

Participants in the usual care arm will receive care as normal and will not attend classes but will complete the same assessments as participants in the BMT and BT classes.

Sponsors & Collaborators

• University of California, Los Angeles

  collaborator OTHER

• University of New Mexico

  collaborator OTHER

• Rutgers, The State University of New Jersey

  lead OTHER

Principal Investigators

• Anita Y Kinney, PhD, RN · Rutgers, The State University of New Jersey

• Michael R. Irwin, MD · University of California, Los Angeles

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

55 Years

Sex

MALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-07-31

Primary Completion

2023-03-07

Completion

2023-03-07

Countries

• United States

Study Locations